U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

Bluebird bio to cut 25% of jobs in fresh bid to battle cash crunch September 24, 2024 Britain's National Health Service (NHS) will begin to roll out a gene therapy from Vertex Pharmaceuticals and ...

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

Report with the AI impact on market trends - The global biotech market size is estimated to grow by USD 805.6 billion from ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program that helps state Medicaid programs pay for expensive cell and gene therapy.

A new painkiller was approved by the Food and Drug Administration (FDA) on Thursday, and is one step closer to making its way ...

Wall Street will continue to digest the big flow of news from the last few weeks, including the Fed meeting and the recent data on inflation and jobs. The Dow Jones Industrial Average ended last ...

Below, check out the roundup of California Healthline's coverage. For today's national health news, read KFF Health News' Morning Briefing.

(Reuters) - Wall Street's main indexes were set to open higher on Friday on gains in Apple following its strong sales ...